144 related articles for article (PubMed ID: 37227518)
1. Interrater reproducibility of the Myoton and durometer devices to quantify sclerotic chronic graft-versus-host disease.
Ghosh S; Baker L; Chen F; Khera Z; Vain A; Zhang K; Hood A; Smith H; Chen H; Jagasia M; Tkaczyk E
Arch Dermatol Res; 2023 Nov; 315(9):2545-2554. PubMed ID: 37227518
[TBL] [Abstract][Full Text] [Related]
2. Reproducibility of the durometer and myoton devices for skin stiffness measurement in healthy subjects.
Dellalana LE; Chen F; Vain A; Gandelman JS; Põldemaa M; Chen H; Tkaczyk ER
Skin Res Technol; 2019 May; 25(3):289-293. PubMed ID: 30414198
[TBL] [Abstract][Full Text] [Related]
3. Interrater Reliability of Clinical Grading Measures for Cutaneous Chronic Graft-vs-Host Disease.
Cardones AR; Sullivan KM; Green C; Chao NJ; Rowe-Nichols K; Bañez LL; Burton CS; Horwitz ME; Long GD; Rao CL; Sarantopoulos S; Sidhu-Malik N; Sung AD; Hall RP
JAMA Dermatol; 2019 Jul; 155(7):833-837. PubMed ID: 30994873
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease.
Baumrin E; Baker LX; Byrne M; Martin PJ; Flowers ME; Onstad L; El Jurdi N; Chen H; Beeghly-Fadiel A; Lee SJ; Tkaczyk ER
JAMA Dermatol; 2023 Apr; 159(4):393-402. PubMed ID: 36884224
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive measurement of sclerosis in cutaneous cGVHD patients with the handheld device Myoton: a cross-sectional study.
Chen F; Dellalana LE; Gandelman JS; Vain A; Jagasia MH; Tkaczyk ER
Bone Marrow Transplant; 2019 Apr; 54(4):616-619. PubMed ID: 30287938
[No Abstract] [Full Text] [Related]
6. Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease.
Hansen JL; Juckett MB; Foster MA; Rumble ME; Morris KE; Hematti P; Costanzo ES
J Cancer Surviv; 2023 Jun; 17(3):646-656. PubMed ID: 36917433
[TBL] [Abstract][Full Text] [Related]
7. Optimal biomechanical parameters for measuring sclerotic chronic graft-versus-host disease.
Baker LX; Chen F; Cronin A; Chen H; Vain A; Jagasia M; Tkaczyk ER
JID Innov; 2021 Sep; 1(3):. PubMed ID: 34790906
[TBL] [Abstract][Full Text] [Related]
8. The Anatomic Distribution of Skin Involvement in Patients with Incident Chronic Graft-versus-Host Disease.
Gandelman JS; Zic J; Dewan AK; Lee SJ; Flowers M; Cutler C; Pidala J; Chen H; Jagasia MH; Tkaczyk ER
Biol Blood Marrow Transplant; 2019 Feb; 25(2):279-286. PubMed ID: 30219700
[TBL] [Abstract][Full Text] [Related]
9. Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial.
Merkel PA; Silliman NP; Denton CP; Furst DE; Khanna D; Emery P; Hsu VM; Streisand JB; Polisson RP; Akesson A; Coppock J; van den Hoogen F; Herrick A; Mayes MD; Veale D; Seibold JR; Black CM; Korn JH; ;
Arthritis Rheum; 2008 May; 59(5):699-705. PubMed ID: 18438905
[TBL] [Abstract][Full Text] [Related]
10. Advanced sclerosis of the chest wall skin secondary to chronic graft-versus-host disease: a case with severe restrictive lung defect.
Ödek Ç; Kendirli T; İleri T; Yaman A; Fatih Çakmakli H; Ince E; İnce E; Ertem M
J Pediatr Hematol Oncol; 2014 Oct; 36(7):e473-5. PubMed ID: 24577553
[TBL] [Abstract][Full Text] [Related]
11. A single-center pilot validation study of a new chronic GVHD skin scoring system.
Greinix HT; Pohlreich D; Maalouf J; Soukup P; Supper V; Kalhs P; Knobler RM
Biol Blood Marrow Transplant; 2007 Jun; 13(6):715-23. PubMed ID: 17531782
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease.
Clark J; Yao L; Pavletic SZ; Krumlauf M; Mitchell S; Turner ML; Cowen EW
Arch Dermatol; 2009 Aug; 145(8):918-22. PubMed ID: 19687424
[TBL] [Abstract][Full Text] [Related]
13. A stretchable hardness sensor for the assessment of skin disease in systemic sclerosis.
Wang X; Liu M; Ye T; Huang J; Xu X; Li M; Zhao X; Lu H; Yang J
RMD Open; 2023 Nov; 9(4):. PubMed ID: 37996124
[TBL] [Abstract][Full Text] [Related]
14. Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidity.
Jachiet M; de Masson A; Peffault de Latour R; Rybojad M; Robin M; Bourhis JH; Xhaard A; Dhedin N; Sicre de Fontbrune F; Suarez F; Barete S; Parquet N; Nguyen S; Ades L; Rubio MT; Wittnebel S; Bagot M; Socié G; Bouaziz JD
Br J Dermatol; 2014 Jul; 171(1):63-8. PubMed ID: 24404963
[TBL] [Abstract][Full Text] [Related]
15. A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.
Mitchell SA; Jacobsohn D; Thormann Powers KE; Carpenter PA; Flowers ME; Cowen EW; Schubert M; Turner ML; Lee SJ; Martin P; Bishop MR; Baird K; Bolaños-Meade J; Boyd K; Fall-Dickson JM; Gerber LH; Guadagnini JP; Imanguli M; Krumlauf MC; Lawley L; Li L; Reeve BB; Clayton JA; Vogelsang GB; Pavletic SZ
Biol Blood Marrow Transplant; 2011 Nov; 17(11):1619-29. PubMed ID: 21536143
[TBL] [Abstract][Full Text] [Related]
16. A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation.
Chirumbolo G; Dicataldo M; Barone M; Storci G; De Matteis S; Laprovitera N; Sinigaglia B; Barbato F; Maffini E; Cavo M; Bonifazi F; Arpinati M
Transplant Cell Ther; 2023 May; 29(5):302.e1-302.e8. PubMed ID: 36796518
[TBL] [Abstract][Full Text] [Related]
17. Oral disease profiles in chronic graft versus host disease.
Bassim CW; Fassil H; Mays JW; Edwards D; Baird K; Steinberg SM; Cowen EW; Naik H; Datiles M; Stratton P; Gress RE; Pavletic SZ
J Dent Res; 2015 Apr; 94(4):547-54. PubMed ID: 25740857
[TBL] [Abstract][Full Text] [Related]
18. Reproducible measurements to quantify cutaneous involvement in scleroderma.
Aghassi D; Monoson T; Braverman I
Arch Dermatol; 1995 Oct; 131(10):1160-6. PubMed ID: 7574833
[TBL] [Abstract][Full Text] [Related]
19. Localization of sclerotic-type chronic graft-vs-host disease to sites of skin injury: potential insight into the mechanism of isomorphic and isotopic responses.
Martires KJ; Baird K; Citrin DE; Hakim FT; Pavletic SZ; Cowen EW
Arch Dermatol; 2011 Sep; 147(9):1081-6. PubMed ID: 21931046
[TBL] [Abstract][Full Text] [Related]
20. Ocular Chronic Graft-versus-Host Disease and Its Relation to Other Organ Manifestations and Outcomes after Allogeneic Hematopoietic Cell Transplantation.
Jeppesen H; Gjærde LK; Lindegaard J; Julian HO; Heegaard S; Sengeløv H
Transplant Cell Ther; 2022 Dec; 28(12):833.e1-833.e7. PubMed ID: 36002105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
